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ABSTRACT: In animal studies, high dosages of corticosteroids cause 
changes in diaphragm structure and function. The present study was de­
signed to Investigate the effects of long-term low-dose methylprednisolone 
(MP) administration on rat diaphragm contractile properties and morphology. 
Thirty adult rats were treated with saline or MP (0.2 mg/kg/day SC) during 6 
months. Contractile properties of isolated diaphragm strips, immunohisto- 
chemical characteristics analyzed by means of antibodies reactive with myo­
sin heavy chain isoforms, and enzyme activities were determined in the 
diaphragm muscle. MP significantly reduced diaphragm force generation by 
-15% over a wide range of stimulation frequencies. The number of type lib 
fibers was reduced by MP, There was a mild but significant decrease in type 
I and lia fiber cross-sectional area (CSA), whereas type llx and lib CSA did 
not change. These changes resulted in a reduction in the relative contribu­
tion of type lib fibers to total diaphragm muscle area. Biochemically, MP 
decreased glycogenolytic activity, while fatty acid oxidation and oxidative 
capacity were increased. In conclusion, long-term low-dose MP administra­
tion caused a marked impairment in diaphragm function. This is accompa­
nied by changes in diaphragm muscle morphology and enzyme capac­
ity. © 1997 John Wiley & Sons, Inc. Muscle Nerve 20: 983-990,1997
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T reatm ent will) corticosteroids may cause periph­
eral and respiratory muscle dysfunction. Two types 
of steroid-induced myopathies have been described 
in humans, depending on the extent and duration of 
steroid treatment: acute and, more often found in
The mechanisms by which nonfluorinated ste­
roids cause myopathy are partly unknown. In animal 
studies, increased variation in fiber dimensions and 
excess of connective tissue were observed after ad­
ministration of prednisolone 5 mg/kg/clay during 4
clinical practice, chronic steroid myopathy.'1 Weak- weeks/ Cortisone acetate 10 mg/kg/day during 3
ness of the respiratory muscles following low doses of 
methylprednisolone (MP) (average daily dose rang­
ing from 1.4 to 21.ft mg during 6 months) was re­
cently reported in patients with chronic obstructive 
pulmonary disease (COPD).“
‘ Corrospondonco to: Or. P.N.R. Dekhuijzen 
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weeks resulted in myonecrosis, vacuolization, and fi­
ber atrophy.“1 Changes in myosin heavy chain com­
position in the muscle fibers may contribute, since 
myosin heavy chain turnover rate in muscle cells was 
decreased following dexamethasone therapy. 
These myosin heavy chains determine different lev­
els of myosin adenosine triphosphotase (ATPase) ac­
tivity depending on their type (I, Ha, llx, lib) and 
are therefore partly responsible for the differences
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in contractile properties between the different fi­
bers.19,24 Since the fast and most powerful fibers 
(i.e., types IIx and lib) are expected to be most sen­
sible to the side effects of corticosteroids,26 we spec­
ulated that the contribution of fast fibers to total 
muscle area declines and maximal force generation 
decreases following treatm ent with corticosteroids. 
Changes in energy substrate and enzyme activities 
have also been reported  before,20,31 but to what ex­
tent this influences diaphragm contractile properties 
is unclear.
Most of the above-mentioned animal studies were 
performed using relatively high dosages during short 
periods of time. The present study was designed to 
investigate if lower, clinically relevant doses of corti­
costeroids also affect rat diaphragm function. We 
therefore examined functional changes in rat dia­
phragm in response to administration of MP 0.2 
m g /k g /d ay  SC for 6 months. Morphological and 
biochemical parameters were determined to gain in­
sight into possible underlying mechanisms.
METHODS
Study Design, Animals, and Treatm ent. Adult male
outbred Wistar rats (n = 30), aged 18-20 weeks, 
weighing 380 ± 25 g, were randomized into two 
groups: a control group (C), receiving saline 0.2 mL 
SC daily, and MP group, receiving methylpredniso- 
lone hemisuccinate (Sigma Chemicals, Bornem, Bel­
gium) 0.2 mg/lcg SC daily (7 days a week) for 6 
months. With each injection all animals received a 
similar volume (—0.20 mL). The rats were fed ad 
libitum, kept on a 12/12-h light-dark regime, and 
weighed twice weekly. The animals were injected 
daily between 8:30 and 10:00 AM. Although daily 
food intake was n o t accurately quantified (animals 
were not kept in metabolic cages), food intake ap­
peared to be similar in both groups. At the end of 
the treatm ent period, contractile properties, and im- 
munohistochemical and biochemical characteristics 
of the diaphragm were examined. All MP-treated 
animals were investigated between 23 and 30 h  after 
the last injection with MP* The study was approved 
by the Animal Experiments Committee of the Uni­
versity of Nymegen and performed according to the 
Dutch National Guidelines of Animal Care.
Contractile Properties. At the end of the treatment 
period, the rats were anesthetized with sodium pen­
tobarbital (70 m g /k g  IP). A polyethylene cannula 
was inserted through a tracheotomy for mechanical 
ventilation (oxygen-enriched gas mixture, flow 0.5 
m L /g  body weight/m in, respiration frequency 70/ 
min, and a duty cycle of 50%). A combined laparot­
omy and thoracotomy was performed to remove the 
diaphragm. Immediately after excision the dia­
phragm was immersed in a cooled, oxygenated 
Krebs solution at a pH of 7.4. This solution consisted
of (mmol/L): 137 NaCl, 4 KCL, 2 MgCl2, 1 KHaP 0 4, 
24 NaHCOs, 2.7 CaCl2, and  7 glucose. D-tubo- 
curarine chloride 25 ]amol/L (Sigma Chemicals, 
The Netherlands) was added to prevent spontaneous 
neuromuscular activity. Contractile properties were 
measured on two small rectangular bundles, dis­
sected from the middle part of the lateral costal re­
gion of each hemidiaphragm and parallel to the 
long axis of the muscle fibers. Silk sutures were 
firmly tied to both ends of the bundle to serve as 
anchoring points. Each bundle was placed in a tissue 
bath containing Krebs at 37°C and was oxygenated 
with 95% 0 2 and 5% COa. The central tendon in­
sertion of the bundles was tied to a fixed point and 
the costal margin origin to an isometric force trans­
ducer (Sensotec, model 31/1437, Columbus, OH). 
Data acquisition and storage were performed using a 
Dash-16 interface and Twist-Trigger software (I.D.- 
electronics, University of Nijmegen, The Nether­
lands). The stimulator (LD.-electronics, University 
of Nijmegen) was activated by a personal computer. 
The muscle strips were stimulated with two large 
platinum electrodes on both sides of the muscle. To 
ensure supramaximal stimulation, subsequent stimu­
lations were performed 20% above the voltage at 
which maximal forces were obtained (~6 V). The 
pulse duration was set on 0.2 ms. Twitch stimuli were 
used to determine the optimal length (Lo), followed 
by a 15-min thermoequilibration period. The follow­
ing measurements were made:
Twitch Charac Leris Lies. Two twitches were re­
corded at Lo to obtain maximal twitch force (PL), 
contraction time (CT), and half relaxation time 
( !/s>RT) .The averages were used for further analysis.7
M aximal Tetanic Contraction, Two maximal te­
tanic stimuli (with a frequency of 160 Hz and a train 
duration of 250 ms) were generated to obtain maxi- 
mal tetanic force (PQ) .
Force-Frequency Protocol Muscle bundles were 
stimulated every 2 min at the following frequencies: 
25, 50, 80, 120, and 160 Hz (train duration 250 ms).
The generated force was expressed per cross- 
sectional area (N/crn2), Cross-sectional area (CSA) 
was measured by dividing diaphragm bundle weight 
by muscle density (1.056 m g /m m 3) and bundle 
length.21
Histological and Immunohistochemical Procedures.
Muscle strips obtained from the costal part of the 
r igh t hem id iaph ragm  were em b ed d ed  in Tis-
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sue- I ek0) in a phislic holder. 1 he muscle fibers were nmol HADH oxiclized/min per g tissue, Citrate 
oriented parallel to the long side ol the holder. Sub- synthase activity was determined at 25°C^7 and was 
sequently, !lu\se specimens were quickly frozen in expressed as pmol coenzyme A formed/min per g 
isopentane cooled in liquid No followed by further tissue. The assays for metabolic enzymes were per­
formed spectrophotometrically in duplicate. The co­
efficient of variation for the assays applied was -5%.
freezing in liquid NtJ. During this procedure, the 
diaphragm muscle bundles were not fixed at optimal 
length. Serial cross sections were cut at 7 pm with a 
cryoslat kepi, at Diaphragm sections were
taken from each group for routine hematoxylin and 
eosin (II&K) staining.
Anlimyosin heavy chain antibodies (Regeneron 
Pharmaceuticals, New York, NY) were used for mor-
Data Analysis. The SPSS/PC-t- package V5.0.1 
(Chicago, IL) was used for statistical analysis. Data of 
contractile properties of the two bundles obtained 
from 1 rat were averaged and compared using Stu­
dent’s /-test. Repeat.ed~measures analysis of variance
phometric examination ol serial diaphragm sections. was used for force—frequency and growth curve
The Following antibodies were used; BA-D5 reactive analysis. Morphometrie analysis was performed using
with type I myosin heavy chains (MIids), SC-71 re- an average per fiber type per animal, which was uti-
activc with type (la Ml Ids, BP-35 reactive with type I, 
11a, and lib but not with type* llx MIKIs, and BF-F3
I j  pi
reactive with type lib MIlCs.“’’ Incubation with myo­
sin heavy chain antibodies was performed at room 
temperature for I h. Antibodies were subsequently 
labeled with ultrasmall immunogold reagent, fol-
lized as a single value in the statistical analysis. Re­
sults were considered significant at P <  0.05. All data 
were expressed as mean ± SE.
RESULTS
Body Weight. No differences in body weight were
lowed by silver enhancement (Aurion, Wageningen, observed at the start of the study (375 ± 7 mg in
The Netherlands). Of each diaphragm a minimum 
of 350 libers was analyzed using a Spryut-based, PC- 
Image digital analysis system (Bos Inc., Waddinx- 
veen, The Netherlands). Fiber type distribution and
saline vs, 385 ± 4 mg in MP). At the end of the 
(5-month treatment period, body weight in the MP- 
treated animals was 5% lower compared to the sa- 
line-treated rats (500 ± 5 mg in MP vs. 529 ± 9 mg in
(ISA were analyzed for type I, 11a, llx, and lib dia- saline). Repeated measurements showed a signifl- 
phragm muscle libers. The relative contribution to cant effect of treatment on body growth during the 
total diaphragm muscle area per fiber type was cal- 6-month study period.
culated as the product of the mean (ISA and fiber 
distribution in the diaphragm.
Biochemistry» Parameters of the bioenergetic ca­
pacity of the diaphragm included the activities of the 
glycogenolytic enzyme phosphoryluse, the mitochon­
drial enzymes 3-hydroxyacyl-CoA dehydrogenase 
(IIADII), a marker for the fatty acid oxidation ca­
pacity, and citrate synthase ((IS), an index of citric 
acid cycle activity.
* 9
After dissection of the diaphragm, fat. and ten­
don were removed from what was left of both 
hem idiaphragm s. These diaphragm parts were 
quickly frozen in liquid N.j and stored at. ~80°(I. Seg­
ments of fresh frozen diaphragm were (hawed in 
ice-cooled buffer containing 250 mmol/L sucrose, 2 
mmol/1, edetic acid, and 10 nnnol/L Tris-IlCIl (pH 
7.*1). In this buffer muscle homogenates (5% wt/vol) 
were prepared by hand homogenizalion, using a Pot- 
ter-Klvehjem glass-tellon homogenizer.
Total phosphoiyliisc (a + b) activity was assayed at 
37"(I according to the method described byjacobs et 
al.,H> and was expressed as pmol NADPH formed/ 
min per g tissue. IIADII activity, assessed at 50 
pmol/L acetoacyl-CoA at 37t,(I,1 was expressed in
Contractile Properties. Diaphragm bundle dimen­
sions were equal in both groups (saline vs. MP: 
length 21.7 ± 0.3 mm vs. 21.3 ± 0.3 mm, thickness
0,62 t  0.01 mm vs. 0.02 ± 0.01 mm, width 2.13 ± 0.06
mm vs. 2.12 ± 0,05 mm, and weight 31.2 ± LI mg vs. 
31.5 ± 0.8 mg).
Both P, and P() decreased by -14% following MP 
administration (P < 0,001) (Table 1). No changes 
were observed in Pt/P<, ratio, CT, or 14RT (Table 1).
The fore e-frequency  curves, expressed in 
N /c n r ,  showed a significant reduction in force gen­
eration at all stimulation frequencies in the MP 
group (Fig. 1). When normalized for P(J, forces were 
similar in the two groups (data not shown).
Histology and Itnmunohistochemistry. Histological 
examination of H&E-stained slides of the diaphragm 
showed a normal muscular pattern in both groups. 
No signs of myogenic alterations such as an increase 
in the number of nuclei, excessive variations in fiber 
dimensions, and excess of connective tissue were 
found.
Morphometric analysis of the immunohisto- 
chemically stained slides showed a significant reduc-
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Table 1. Diaphragm contractile properties.
/
T reatment Pt (N/cm2) CT (ms) V^RT (ms) P0 (N/cm2) p,/p0
Control 7.7 ± 0.02 25.7 ± 0.5 23.1 ±0.3 27.1 ±0.06 0.29 ±0.01
MP 6.6 ± 0.01* 26.0 ± 0.5 22.9 ± 0.3 23.4 ± 0.06* 0.29 ± 0.01
Means ± SE.
Pv twitch force; CT, contraction time; IÆRT, half relaxation time; P0, maximal tetanic force. 
*P <0.001 compared to control.
tion in the percentage of type lib fibers in the MP 
diaphragm (1.8 ± 0.4% compared to 4.8 ± 0.6% in 
the control group, P <  0.05) (Table 2). No significant 
changes were found in the numbers of type I, Ha, 
and IIx fibers between the two groups.
Small but significant reductions in type I and Ha 
fiber CSA were observed in the MP group. In con­
trast, no changes were found in type IIx and lib fiber 
CSA (Table 2)* The distribution of fiber CSA per 
fiber type is shown in Figure 2. The histogram for 
type lib fibers illustrates that the MP-induced de­
crease in num ber of lib  fibers occurred without pref­
erence for fiber size. This explains the similarity in 
fiber CSA between MP and control. As a result of the 
changes in num ber and CSA of die different fiber 
types, the relative contribution of type Hb fibers to 
total diaphragm muscle areas was reduced in the MP 
group, while the contribution of type IIx fibers was 
increased (Table 2).
Biochemistry. MP administration caused a signifi­
cant reduction in glycogenolytic activity, as mea­
sured by phosphorylase (P  < 0.01). Both fatty acid
oxidation capacity, measured by PIADH, and oxida­
tive capacity, indicated by CS activity, increased in
the MP group (P < 0.01) (Table 3).
DISCUSSION
The aim of the present study was to evaluate the kind 
and extent of changes in rat diaphragm caused by 
low-dose administration of MP during 6 months. 
Our data show that MP significantly reduced dia­
phragm force generation over a wide range of stimu­
lation frequencies. This was accompanied by a 
marked reduction in the number of type lib fibers, 
and slight but significant type I and Ha fiber atrophy. 
The combined effect of these morphological alter­
ations was a reduction in the relative contribution of 
type lib fiber CSA to total diaphragm CSA and, con­
versely, an increase in the relative contribution of 
type IIx fibers. In line with these data, there was a 
reduction in phosphorylase activity, combined with 
an increase in markers of oxidative capacity, con- 
fuming a shift toward slower fibers. However, these 
changes in muscle morphology and biochemistry, al­
though statistically significant, were subtle and at
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Table 2. Fiber type distribution, cross-sectional area, and relative fiber type contribution to the total diaphragm muscle area.
Müiitiï* :t: ,S7“.
T  «• (Mh comp;tun I to contivi.
Type Type Ila Type llx Type lib
Fiber typo distribution (%) 
Control 41.6 ± 1.0 27.1 ± 1.1 26.4 ± 0.64 4.8 ± 0.6
MP 43.5 ± 1.6 29.0 ± 1.3 25.7 ± 1.0 1.8 ±0.4*
Fiber CSA Urnr” ) 
Control 1164 ± 95 1403 ± 140 3528 ± 421 5828 ± 599
MP 1041 ±88* 1214± 104* 3532 ±415 5926 ± 557
Fibor typo contribution 
to total diaphragm area (%) 
Control 23.2 ± 0.6 18.4 ±0,4 45.2 ± 1.3 13.2 ±1.3
MP 24.2 ± 0.9 19.8 ± 0.8 50.2 ± 0.7* 5.8 ± 1.3*
most only partly explained tlu: reduction in dia­
phragm Imre generation.
O u r  in te n t io n  was to evaluate the efleets o f 'a  low 
dose o f  a n o n l lu o r in a te d  s tero id  (MP) com parab le
to die close that is occasionally used in chronic treat­
ment of patients with COPI), The MP dose used in 
the present study was based upon the following con­
siderations. Anti-inflammatory potency and metabo-
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Table 3. Biochemical analysis.
Phosphorylase CS HADH
T reatment (U/g) (U/g) (U/g)
Control 42.7 ± 0.9 26.2 ± 0.8 6.19 ± 0.3
MP 38.6 ± 0.8* 31.5 ±1.1* 7.32 ±0.3*
Enzyme activities of the diaphragm (means ± SE). CS, citrate synthase; 
HADH, 3-hydroxyacyt-CoA dehydrogenase.
*P < 0.01 compared to control.
lism of MP have been  described as being similar in 
rats and hum ans,17,25 Assuming an absorption of 
100%, 0.2 m g /kg  of MP may be equivalent to a dose 
of ~14 m g/day in a 70-kg human. This is probably an 
overestimation, since an  absorption of 60% was
< y  1
found after IM injection of cortisone acetate. In 
addition, the SC route requires higher doses to pro-
duce similar effects com pared  to IM administra­
tion.12 Prolonged prednisolone administration in 
doses of 10-15 mg daily are no exception in the 
trea tm ent of patients with COPD, although the 
therapeutic efficacy of corticosteroids in COPD is at 
least controversial.15
To our knowledge, no animal studies have been 
performed using low steroid dosages for a prolonged 
period. In a previous study we found that I m g /k g /  
day MP for 8 weeks depressed the fore e-frequency 
curve in rat diaphragm.31 The clear reduction in dia­
phragm force, as observed in the present study, was 
not found before following 0.5 mg M P/kg/day for 6 
weeks,5 or following 5 m g /k g /d ay  of prednisolone 
for 4 weeks.7 Cortisone acetate in a dose of 100 m g / 
k g /d a y  for 10 days d id  n o t  induce  functional 
changes either.21 The discrepancy with the present 
data suggests that diaphragm impairment is likely to 
occur following low dosages of corticosteroids, par­
ticularly if they are administered for prolonged pe­
riods.
At the end of the 6-month treatment period, 
body weight in the MP animals was 5% lower com­
pared to the control group. The question may arise 
to what extent this reduction in body weight growth 
may influence diaphragm force production. Severe 
nutritional depletion (40% decrease in body weight 
over a period of 6 weeks) did no t lead to a reduction 
in diaphragm force production in rats.b In addition, 
in the same study, nutritional depletion caused a 
-30% decrease in type I and Ha fiber CSA, while type 
lib fiber CSA decreased by —50%. Since these find­
ings are substantially different from the morphomet- 
ric results in the present study following MP, the 
observed differences in force production are not 
likely to be the result of the small difference in final 
body weight.
Since diaphragm bundle dimensions were similar 
in both groups, the reduced force generation of the 
MP-treated diaphragm is unlikely to be caused by 
differences in oxygenation of these muscle strips, An 
overestimation of the CSA due to increased extracel­
lular fluid is unlikely, since MP has little or no min~ 
eralocorticoid activity.14 An increase in connective 
tissue, as noticed previously in the diaphragm follow­
ing prednisolone treatm ent (5 m g /kg /day  for 4 
weeks),7 may also lead to an overestimation of the 
muscle CSA and therefore reduce force per CSA. 
However, differences in connective tissue propor­
tion in the diaphragm muscle were not observed in 
the present study. Pathologic features like myonecro­
sis,7,9 vacuolization,7,9 excess of internal nuclei, and 
larger than normal variation of fiber type diameter 
were described following administration of prednis- 
olone 5 m g/kg/day for 4 weeks, and cortisone ac­
etate 10 m g/kg daily for 3 weeks,9 respectively. None 
of the above-mentioned pathologic changes, how­
ever, occurred in the present study, possibly as a 
result of the low dose studied.
Another explanation for the functional changes 
in this study may be a change in fiber distribution 
and size. Our data did indeed show that MP admin­
istration caused small but significant changes in 
muscle morphometry. First, a significant reduction 
in the percentage of type lib  fibers was found, 
whereas no changes occurred in the numbers of type
I, Ha, and llx fibers. This is in line with the data by 
Polla et al.,22 who even reported a total disappear­
ance of type lib fibers in rat diaphragm treated with 
cortisone acetate (100 m g/kg  for 11 days). The 
cause of this phenomenon is not entirely clear. Cor­
ticosteroids decrease the rate of amino acid incorpo­
ration into MHCs, resulting in a decreased turnover 
rate of MHCs in the muscle cell. 1 This decrease in 
turnover rate is most pronounced in the fast twitch 
muscle fibers,26 thus type lib fibers are likely to be 
affected most. This may lead to a decrease in lib 
MITCs in type lib fibers. Since genes of llx MHCs are 
coexpressed in a number of type lib muscle fibers,8 
it may be speculated that an increase of llx MHCs in 
type lib muscle fibers may occur to compensate for 
the decrease in type lib MHCs.
Second, significant but small reductions in type I 
and Ha fiber CSA were observed in the MP group, 
while type llx and lib fiber CSA were not altered. 
Previous studies using ATPase-based fiber typing 
showed no effect of pi’ednisolone7 and MP5 on rat 
diaphragm fiber size and composition. In another 
study, atrophy of type I, Ila, and lib fibers was ob­
served after administration of cortisone acetate (10 
m g/kg  daily for 3 weeks) in rabbits.9 Dose and du­
«
988 Corticosteroids and Respiratory Muscles MUSCLE & NERVE August 1997
ration of treatment with steroids presumably explain
these differences,
)
When combining the two types of alterations de­
scribed above, the relative contribution of type lib 
fibers to total diaphragm muscle area was reduced in 
the MP group, while the contribution of type llx 
libers increased. This might he of functional signifi­
cance, since type llx and lib MHCs possess differ­
ence's in contractile properties. Maximum velocity of 
shortening“'1 and resistance to fatigue19 in type llx 
muscle fibers are intermediate between those of type 
fla and lib fibers, in addition, twitch and tetanic are 
higher in lib compared to 11a and llx motor units,H) 
However, it must be stressed that the morphological 
changes in the present study were small Conse­
quently, it is unlikely that these alterations com­
pletely explain (lie changes in diaphragm contractile
properties,
A methodological point of consideration is that 
diaphragm muscle morphology in the present study 
may have been influenced by the fact, that the muscle 
strips were not fixed at optimal length before freez­
ing. 'The excised diaphragm bundle was therefore 
allowed to assume its equilibrium length, resulting in 
shortening of the muscle. The degree of shortening 
is associated with loss of passive tension present in 
vivo/0 In our study this passive muscle tension was 
similar in the control and the MP group (0.038 ± 
0.01 and 0.037 t 0,01 N). As a consequence, the 
degree of muscle shortening (and thus the change 
in fiber CSA) is not likely to I k * different between 
control and MP. This, however, does not exclude the 
possibility of a disproportion in degree of shortening 
between liber types. In addition, the differences in 
CSA between type 1, 11a, llx, and III) fibers in the 
control group wen* in proportion to the differences 
in (ISA when muscle strips were fixed at optimal 
length.'5'1 Thus, the physiological differences in size 
between the different liber types did not appear to 
he affected by muscle shortening in the present 
study.
>
In line* will) the* small shift toward slower fiber 
types, glycogenolytic activity decreased and oxidative 
capacity increased following MP treatment. The in­
crease in glycogen storage in the diaphragm muscle 
following steroid administration found by previous 
investigators11* is the result of a decrease in glycogen 
breakdown or an increase in glycogen production,“ 
or both .11 This reduction in glycogenolytic’ activity 
may result in an increase in diaphragm muscle de­
pendence on fatty acid oxidation capacity of fatty 
acids to provide acetyl-CoA for mitochondrial oxida­
tion. Indeed, IIADII activity increased in the MP
tion capacity, although 10 days of prednisolone (5 
m g/kg/day SC)20 or 8 weeks of MP (1 m g /k g /
I )  1 ___
day)' did not change HADH activity. The increase 
in oxidative capacity in this study corresponds with 
our morphometrical observations, since type llx 
muscle fibers are known to have a rich mitochon­
drial content in contrast to type lib fibers.25 This is 
in line with the increase in oxidative staining reac­
tion in skeletal muscle reported previously.32 An in­
crease in CS activity was also found following MP 1 
m g /k g /d ay /1 In contrast to these observations, CS 
activity in rat diaphragm was reduced following 5 
mg/kg prednisolone per day for 10 clays/0 Yet, no 
changes in CS activity were reported following 0.5,1, 
or 2 mg/kg per day /0 suggesting that CS activity was 
only reduced after administration of high dosages of 
prednisolone.
Besides depending on dose and duration of the 
steroid, changes in metabolism due to corticoste­
roids may also be related to fiber type composition of 
the m uscle/0,20 The resistance of different fiber 
types is believed to depend on their ability to com­
pensate the steroid-induced deficiency of the glyco­
genolytic route by converting to oxidative metabo­
lism /" It remains unclear if these biochemical 
changes are also responsible for the changes in fiber 
types or, in turn, whether this shift is responsible for 
the biochemical changes.
Since the changes in muscle morphology and 
biochemical capacity in the present study are likely 
to be responsible for part of the reduction in muscle 
force generation, other alterations are presumably 
also involved. For example, protein degeneration, 
caused by corticosteroids, may lead to a reduction in 
myofibrillar protein density.18 This is likely to reduce 
the number of cross-bridges available for interaction 
with actin, which will lead to a reduction in force 
generation. Further studies are required to explore 
these potential changes.
The observed reduction in force generation fol­
lowing MP administration in this study may be of 
clinical significance in patients with severe COPD, 
since in these patients diaphragm function may be 
compromised as result of hyperinflation, malnutri­
tion, inactivity, disturbances in blood gases, and car­
diac failure.13 Indeed, it has recently been shown 
that in these patients administration of low doses of 
corticosteroids compromises diaphragm function 
even more." The present, study shows that these func­
tional alterations are accompanied by biochemical 
and structural changes in the diaphragm.
group, confirming (his increase in fatty acid oxida- We thank Ms. Yveiu- Brom tor her export foioteclmiail assistance.
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